Business Wire

MI-EATON

7.3.2024 12:31:34 CET | Business Wire | Press release

Share
Eaton Receives Two Grants From the Czech Republic, Continues to Expand Mobility Capabilities and Resources in Europe, Middle East, and Africa

Intelligent power management company Eaton continues to expand its capabilities and resources in Europe, Middle East, and Africa (EMEA) with the recent announcements of two grants from the Czech Republic. The grants will fund participation in two innovative mobility projects, including assisting in the design and development of an electrified off-road truck and to develop and demonstrate a new power distribution unit (PDU) and DC/DC converter (200 kW) for hydrogen fuel cell powered trucks.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240307921565/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Eaton’s power distribution unit will be utilized in two electrified vehicle projects funded by grants from the Czech Republic. (Photo: Business Wire)

“We are continuously expanding our electrified vehicle capabilities in EMEA and forming meaningful partnerships with governments and automotive manufacturers and suppliers,” said Dr. Mihai Dorobantu, director, Technology Planning and Government Affairs, Eaton’s Mobility Group. “EMEA is an important growth region for electrified vehicles, and we are proud to help pave the way to an emissions-free future.”

One of the grants from the Czech Republic is to participate in a joint program with Tatra Trucks, a leading Czech truck manufacturer for both military and commercial applications, to produce a specialized off-road electrified truck, a prototype called the Battery Electric Tatra Truck with multi-speed Transmission (BETTT). Eaton’s contribution to the endeavor will be the integration of its power distribution unit (PDU) and award winning 4-speed transmission for medium- and heavy-duty electrified vehicles (EVs).

“We’re very excited to have been chosen to participate in this important project,” Dorobantu said. “Eaton strives to be at the forefront of innovation for all types of vehicles as the mobility industry continues its transition from internal combustion-powered vehicles to those with electrified drivetrains.”

Medium- and heavy-duty vehicle requirements are fundamentally different than passenger vehicles. Because larger vehicles, such as buses and trucks, are bigger and heavier than passenger vehicles, electrified versions require large electric motors and batteries, which add cost. However, many vehicles typically operate on routes with significant braking opportunities that generate power via regenerative braking, making electrification an attractive opportunity to reduce energy and improve performance simultaneously.

The 4-speed EV transmission, a part of Eaton’s eMobility portfolio of electrified vehicle components, solves the primary issue related to single-speed drives: contradictory requirements for high efficiency at top speeds and increased torque at launch and low speeds. It also promotes a more complete brake energy regeneration that reduces total energy consumption and battery needs.

Eaton’s PDUs connect the main battery power to the rest of the vehicle, similar to how a home service panel connects the main power source to each of the branch circuits in the house. While distributing power through the vehicle, the PDU, also known as junction boxes, or fuse boxes, also provides a safety function, protecting passengers and the vehicle’s expensive power electronics from short circuits and other electrical system faults.

“Eaton’s PDU leverages our extensive automotive experience and electrical expertise to ensure complete power protection with enhanced vehicle performance and efficiency,” Dorobantu said. “The BETTT project will allow us to gain knowledge from a specific application and demonstrate the performance benefits of our components on a system level.”

Eaton’s second grant is from the Czech government program DEFACTo (Definition and Demonstration of Fuel Cell BoP and DC/DC components) for a three-year program to develop and demonstrate a new PDU and DC/DC converter (200 kW) for hydrogen fuel cell powered trucks. In addition, an internal test bench with a fuel cell system (50 kW) will be set up at the Eaton European Innovation Center (EEIC) to expand and accelerate the company’s capabilities and developments in the field of hydrogen.

“To successfully complete this project, we are establishing a hydrogen fuel cell lab at our European Innovation Center in Prague to test out different fuel cell components, including air and hydrogen control systems, as well as working to integrate a fuel cell in a simulated vehicle or building,” Dorobantu said.

Learn more about Eaton’s EV transmission and PDU.

Eaton is an intelligent power management company dedicated to protecting the environment and improving the quality of life for people everywhere. We make products for the data center, utility, industrial, commercial, machine building, residential, aerospace and mobility markets. We are guided by our commitment to do business right, to operate sustainably and to help our customers manage power ─ today and well into the future. By capitalizing on the global growth trends of electrification and digitalization, we’re accelerating the planet’s transition to renewable energy sources, helping to solve the world’s most urgent power management challenges, and building a more sustainable society for people today and generations to come.

Eaton was founded in 1911 and has been listed on the New York Stock Exchange for more than a century. We reported revenues of $23.2 billion in 2023 and serve customers in more than 160 countries. For more information, visit www.eaton.com. Follow us on LinkedIn.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240307921565/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release

If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids

Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release

Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use

DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release

-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating

HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 11:18:00 CEST | Press release

HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi

Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 10:28:00 CEST | Press release

Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye